These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7490785)

  • 1. [General pharmacological study of iodixanol, a new non-ionic isotonic contrast medium].
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Makino M; Hagiwara T; Hirohashi M; Nomura M; Algate DR
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():133-51. PubMed ID: 7490785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit.
    Sundgren P; Bååth L; Maly P
    Acta Radiol; 1995 May; 36(3):307-11. PubMed ID: 7742128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of iodixanol and iopamidol on hemodynamic and cardiac electrophysiologic parameters in vitro and in vivo.
    Dundore RL; Silver PJ; Ezrin AM; Lee KC; Buchholz RA; van Aller G; Clas DM; Roth GM; Harnish PP; Bailey DM
    Invest Radiol; 1991 Aug; 26(8):715-21. PubMed ID: 1917406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW; Dukovic D; Pagani E
    Acad Radiol; 1995 Jan; 2(1):33-7. PubMed ID: 9419521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preclinical evaluation of iotrolan as a contrast medium for angiography and urography].
    Miyazawa T; Murayama C; Uchimoto R; Fritz-Zieroth B
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1287-98. PubMed ID: 1437534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central effects of iohexol and iopamidol, non-ionic contrast media].
    Kisara K; Sakurada S; Tadano T; Sakurada T; Tan-No K; Usui C; Kitano Y; Takasuna K
    Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):269-80. PubMed ID: 8514209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iodixanol, iopentol, iohexol and metrizoate on femoral blood flow after injection into the femoral artery of the dog.
    Almén T
    Acta Radiol Suppl; 1987; 370():69-72. PubMed ID: 2980316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodixanol in intravenous urography: a comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM).
    Conroy RM; Bjartveit K; Sheppick A; Long U; Masterson J
    Clin Radiol; 1994 May; 49(5):337-40. PubMed ID: 8013200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodixanol in paediatric excretory urography: efficiency and safety compared to iohexol.
    Dacher J; Sirinelli D; Boscq M; Hassan M; Garel C; Chateil JF; Amar C
    Pediatr Radiol; 1998 Feb; 28(2):112-4. PubMed ID: 9472058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta.
    Pitman MR; Karlsson JO; Griffith TM
    Br J Pharmacol; 1996 Oct; 119(4):685-90. PubMed ID: 8904642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.